Copper and iron are the two transition metals most central to human energy metabolism. Iron is the oxygen-carrying atom in haemoglobin and myoglobin; copper is a cofactor for cytochrome c oxidase, the enzyme that transfers electrons from cytochrome c to oxygen in the final step of the mitochondrial electron transport chain. When one is deficient, the other accumulates — and this competition has profound effects on energy production, neurological function, and blood sugar regulation.
The Ceruloplasmin Connection
Ceruloplasmin is the primary copper-carrying protein in the blood — it binds approximately 95% of circulating copper. But ceruloplasmin has another critical function: it oxidises iron from the ferrous (Fe2+) to the ferric (Fe3+) state, which is the form that can be bound by transferrin for transport. This oxidation step is required for iron to be mobilised from storage sites in the liver, spleen, and bone marrow. Without adequate ceruloplasmin — which requires copper to be synthesised — iron accumulates in storage sites while becoming functionally unavailable for utilisation.
This is the mechanism behind aceruloplasminemia — a rare genetic disorder in which ceruloplasmin is not produced — and a related condition called Wilson’s disease, in which copper metabolism is disrupted. Both conditions produce iron accumulation in the brain and liver, causing neurological symptoms, liver cirrhosis, and psychiatric disturbance. At the subclinical level, low ceruloplasmin from marginal copper deficiency produces a similar pattern of functional iron deficiency despite normal ferritin and serum iron levels.
Copper and the Electron Transport Chain
Cytochrome c oxidase (Complex IV of the electron transport chain) requires copper as well as heme iron for its function. This enzyme transfers electrons from cytochrome c to molecular oxygen, producing water and generating the proton gradient that drives ATP synthesis. When copper is deficient, Complex IV activity falls, and the electron transport chain backs up — producing a bottleneck that reduces the overall efficiency of mitochondrial ATP production. Cells compensate by increasing glycolysis and lactate production, which can produce a subclinical lactic acidosis during exercise.
Athletes with marginal copper deficiency often report exercise intolerance disproportionate to their training status, poor recovery between efforts, and a sensation of heaviness in the legs during aerobic exercise. These symptoms are attributable to reduced electron transport chain efficiency at the cytochrome c oxidase step, which limits maximum aerobic capacity.
The Iron-Copper Ratio
A high iron-to-copper ratio — common in people with iron overload or hemochromatosis, or in those taking high-dose iron supplements — can produce functional copper deficiency through competitive absorption inhibition. Similarly, high copper intake can interfere with iron utilisation and produce a pattern resembling iron deficiency. The ideal ratio by weight is approximately 10-15:1 iron to copper in the diet, though this is difficult to achieve precisely through food alone.
The practical implication for iron deficiency anaemia is that iron supplementation without adequate copper will not fully correct the anaemia, because iron requires ceruloplasmin (copper-dependent) for proper mobilisation. When prescribing iron for anaemia, 1-2mg of copper daily as copper glycinate or copper gluconate should accompany it for optimal effect.
Food Sources and Supplements
The best food sources of copper include liver, shellfish (particularly oysters), dark chocolate, nuts (cashews, almonds), and seeds (sesame, sunflower). These foods, consumed several times per week, maintain adequate copper status for most people. Copper supplementation at doses above 2mg daily is generally not warranted except in specific clinical scenarios, because the therapeutic window between adequate copper and copper toxicity is narrower than for most minerals. The upper tolerable limit for copper from supplements is 10mg daily — intakes above this can cause liver damage over time.
Iron Role in Brain Energy Metabolism
Iron is essential for brain function far beyond its role in haemoglobin and oxygen transport. The brain consumes approximately 20% of the body oxygen despite accounting for only 2% of body weight, and iron is critical in this energy metabolism — particularly in the electron transport chain within mitochondria, where iron-sulfur clusters are essential components of Complexes I, II, and III. Iron is also a cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, and for ribonucleotide reductase, the enzyme required for DNA synthesis. These roles mean that iron deficiency — even without frank anaemia — can impair dopaminergic signalling, reduce neural energy production, and compromise myelin formation, with measurable effects on attention, memory, and executive function.
Why Iron Deficiency Is So Common
Iron deficiency is the most common nutritional deficiency worldwide, affecting an estimated 2 billion people. In menstruating women, iron deficiency is particularly prevalent due to monthly menstrual blood loss — even a “normal” menstrual iron loss of 30-40ml per cycle can gradually deplete iron stores over months to years. In men and post-menopausal women, iron deficiency should always be investigated as it can signal occult gastrointestinal blood loss. The symptoms of iron deficiency extend well beyond fatigue and pallor: restless legs syndrome (strongly associated with brain iron deficiency), impaired thermoregulation, reduced exercise tolerance, and cognitive impairment in both children and adults.
Iron Status: Not Just Haemoglobin
The standard diagnostic marker for iron deficiency is haemoglobin — but this misses the majority of iron-deficient people, because haemoglobin only falls after iron stores (ferritin) are already significantly depleted. Ferritin is the storage form of iron, and a level below 30 ng/mL indicates depleted stores, while anything below 15 ng/mL indicates frank deficiency. Optimal ferritin for cognitive function appears to be in the range of 50-100 ng/mL. Iron supplementation should always be guided by ferritin testing, not haemoglobin alone, and excessive iron (from over-supplementation or haemochromatosis) carries its own serious risks including liver cirrhosis and increased infection risk through iron-dependent pathogen growth.
A quality supplement routine can make a real difference to your results.
Leave a Reply